| 교수진 명단
관련/관심분야
데이터가 없습니다.
주요논문
- Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial [ NATURE MEDICINE ] - 2024.03.01
- DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 [ GASTRIC CANCER ] - 2024.01.01
- Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer [ SCIENTIFIC REPORTS ] - 2023.11.16
- A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours [ BRITISH JOURNAL OF CANCER ] - 2023.08.01
- Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma [ CANCER IMMUNOLOGY IMMUNOTHERAPY ] - 2023.02.01
- Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer [ ANTICANCER RESEARCH ] - 2023.02.01
- Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study [ GASTRIC CANCER ] - 2022.11.01
- Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment [ SCIENTIFIC REPORTS ] - 2022.01.31
- Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab [ GASTRIC CANCER ] - 2022.01.01
- Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis [ CLINICAL AND MOLECULAR HEPATOLOGY ] - 2022.01.01
- Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study [ GASTRIC CANCER ] - 2022.01.01
연구과제 수주실적
- 종양-침투 T세포에서 NKG2A 발현에 대한 연구 - 2022.01.20 ~ 2024.02.28
특허/기술이전실적
-
데이터가 없습니다.
국내외 경력
데이터가 없습니다.
공지